CELLEXOSOME HE SR- adenosine liquid 
PROSTEMICS Co., Ltd.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

ACTIVE INGREDIENT

Active ingredients: Adenosine 0.04%

INACTIVE INGREDIENT

Inactive ingredients:

[Powder] HUMAN ADIPOSE DERIVED STEM CELL CONDITIONED MEDIA, Panax Ginseng Root Extract.
[Solvent] Water, Dimethylaminoethanol Tartrate, Tromethamine, 1,2-Hexanediol, Hydroxyacetophenone, Sodium Hyaluronate

PURPOSE

Purpose: Anti wrinkle

WARNINGS

Warnings:
For external use only
1. Discontinue use if signs of irritation or rashes appear. If symptoms get worse, consult with a dermatologist. 1) In case of swelling, itching, or other side effects while or after using this product
2. Do not apply to open wounds.
3. Avoid contact with eyes.
Storage and handling
4. Replace the cap after use
5. Keep out of reach of children.
6. Avoid direct sunlight.

KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN SECTION

Uses

Uses:

Helps improve wrinkle problem

Directions

Directions:

■ Put solvent into the powder ampoule and shake gently enough to dissolve the mixture
■ Take proper amount and gently apply onto the skin

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of carton

CELLEXOSOME HE SR 
adenosine liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62041-300
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Adenosine (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) Adenosine0.002 g  in 6 mL
Inactive Ingredients
Ingredient NameStrength
Water (UNII: 059QF0KO0R)  
DEANOL BITARTRATE (UNII: D240J05W14)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:62041-300-021 in 1 CARTON02/01/2020
1NDC:62041-300-016 mL in 1 CONTAINER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/01/2020
Labeler - PROSTEMICS Co., Ltd. (689605919)
Registrant - PROSTEMICS Co., Ltd. (689605919)
Establishment
NameAddressID/FEIBusiness Operations
Prostemics Co., Ltd. Factory695687674manufacture(62041-300)

Revised: 2/2020
Document Id: b921f2d4-18a5-4911-abb2-c2cc032ffdc8
Set id: a74e4261-5141-4976-8727-a82fefc9f1bf
Version: 1
Effective Time: 20200214
 
PROSTEMICS Co., Ltd.